Shilpa Medicare Raichur facility gets Russian GMP certificate
Hyderabad: Shilpa Medicare Limited has recently announced that the Company's API facility (unit-1) located at Raichur, Karnataka has received GMP certificate from MOH-Russia.
"The facility was audited by the agency on 17 February 2022, 18 February 2022 and 21 February 2022," the company said in a recent BSE filing.
The facility involves in manufacturing, testing, packing, storage of chemically synthesized nonsterile drug substances for human use.
Read also: Shilpa Medicare gets 4 USFDA observations for Hyderabad division
Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India.
The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.
Read also: Shilpa Medicare clears USFDA review for Dabaspet facility
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd